Search results for "nanoparticle"

showing 10 items of 2198 documents

DNA PLASMID DELIVERY INTO HEPATOCELLULAR CARCINOMA CELLS BY COMPLEXATION WITH SOLID LIPID NANOPARTICLES

2014

Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoSOLID LIPID NANOPARTICLES GENE DELIVERY HEPATOCELLULAR CARCINOMA
researchProduct

Effects of kind and amount of surfactants on physical-chemical properties of cationic solid lipid nanoparticles (SLN) for the treatment of hepatocell…

2014

Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoSOLID LIPID NANOPARTICLES HEPATOCELLULAR CARCINOMA
researchProduct

Encapsulation of sorafenib into lipid nanoparticles improves its antitumor activity.

2013

Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoSOLID LIPID NANOPARTICLES SORAFENIB
researchProduct

Microfibers and Nanoparticles with Controlled Dimensions of a Hyaluronic Acid Derivative

2017

Microfluidics is defined as the technology that deals with the precise control and manipulation of small quantities of fluids constrained in micro-channels of small cross-sectional dimensions [1]. Microfluidics has recently emerged as a very promising route for the production of polymeric fibers at the micro and nanoscale, providing a fine control over fiber shape, size, chemical anisotropy and biological activity [2]. Furthermore, the ability to manipulate nanoliter volumes of liquid and to control mixing and reaction precisely, opens up the possibility of creating smart targeted drug delivery systems as nanoparticles, especially with uniform and narrow size distribution [3]. This work des…

Settore CHIM/09 - Farmaceutico Tecnologico Applicativohyaluronic acid microfluidics microfiber nanoparticles
researchProduct

LIPID AND POLYMERIC NANOSTRUCTURES FOR BRAIN DRUG DELIVERY AND TARGETING

2009

Settore CHIM/09 - Farmaceutico Tecnologico Applicativolipid nanoparticles polymeric nanoparticles brain targeting
researchProduct

Galactosylated Polymer/Gold Nanorods Nanocomposites for Sustained and Pulsed Chemo-Photothermal Treatments of Hepatocarcinoma

2022

In this paper, we propose a rational design of a hybrid nanosystem capable of locally delivering a high amount of hydrophobic anticancer drugs (sorafenib or lenvatinib) and heat (hyperthermia) in a remote-controlled manner. We combined in a unique nanosystem the excellent NIR photothermal conversion of gold nanorods (AuNRs) with the ability of a specially designed galactosylated amphiphilic graft copolymer (PHEA-g-BIB-pButMA-g-PEG-GAL) able to recognize hepatic cells overexpressing the asialoglycoprotein receptor (ASGPR) on their membranes, thus giving rise to a smart composite nanosystem for the NIR-triggered chemo-phototherapy of hepatocarcinoma. In order to allow the internalization of A…

Settore CHIM/09 - Farmaceutico Tecnologico Applicativopolyaspartamidedrug deliveryPharmaceutical Sciencenanoparticlessorafeniblenvatinibpolyaspartamide; gold nanorods; sorafenib; lenvatinib; nanoparticles; drug deliverygold nanorods
researchProduct

LIPID NANOPARTICLES AS CARRIERS FOR TARGETED RELEASE OF RILUZOLE INTO THE CENTRAL NERVOUS SYSTEM

2009

Settore CHIM/09 - Farmaceutico Tecnologico Applicativosolid lipid nanoparticles central nervous system drug delivery
researchProduct

LIPID NANOPARTICLE SYSTEMS CONTAINING CURCUMIN: PREPARATION AND CHARACTERIZATION

2008

Settore CHIM/09 - Farmaceutico Tecnologico Applicativosolid lipid nanoparticles curcumin
researchProduct

FERULIC ACID LOADED SOLID LIPID NANOPARTICLES PROTECTS LAN5 NEUROBLASTOMA CELL LINE BY Ab-AMYLOID OXIDATIVE STRESS

2008

Settore CHIM/09 - Farmaceutico Tecnologico Applicativosolid lipid nanoparticles ferulic acid
researchProduct

Lipid nanocarrier for the treatment of hepatocellular carcinoma

2013

Hepatocellular carcinoma (HCC) is the sixth most prevalent cancer and the third most frequent cause of cancer-related death. Unlike most solid tumors the incidence and mortality of HCC have increased in the United States and Europe in the past decade. Most patients are diagnosed at advanced stages, so there is an urgent need for new systemic therapies [1,2]. To improve the delivery of therapeutic agents to tumor cells in vivo it’s necessary to overcome several problems, such as drug resistance at the tumor level due to physiological barriers (non cellular based mechanism), drug resistance at the cellular level (cellular mechanism), drug distribution, biotransformation and clearance of antic…

Settore CHIM/09 - Farmaceutico Tecnologico Applicativosorafeniblipid nanoparticleshepatocelular carcinoma
researchProduct